Davenport & Co’s iShares US Healthcare ETF IYH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.77M | Sell |
26,354
-215
| -0.8% | -$13.5K | 0.01% | 600 |
|
|
2026
Q1 | $1.64M | Sell |
26,569
-117
| -0.4% | -$7.56K | 0.01% | 574 |
|
|
2025
Q4 | $1.74M | Buy |
26,686
+1,204
| +5% | +$76K | 0.01% | 562 |
|
|
2025
Q3 | $1.5M | Sell |
25,482
-422
| -2% | -$24K | 0.01% | 591 |
|
|
2025
Q2 | $1.46M | Buy |
25,904
+164
| +0.6% | +$9.25K | 0.01% | 590 |
|
|
2025
Q1 | $1.57M | Buy |
25,740
+3,555
| +16% | +$217K | 0.01% | 542 |
|
|
2024
Q4 | $1.29M | Buy |
22,185
+5
| +0% | +$309 | 0.01% | 587 |
|
|
2024
Q3 | $1.44M | Sell |
22,180
-1,204
| -5% | -$76.9K | 0.01% | 553 |
|
|
2024
Q2 | $1.43M | Buy |
23,384
+404
| +2% | +$24.3K | 0.01% | 541 |
|
|
2024
Q1 | $1.42M | Buy |
22,980
+1,360
| +6% | +$81.8K | 0.01% | 537 |
|
|
2023
Q4 | $1.24M | Buy |
21,620
+1,780
| +9% | +$96.9K | 0.01% | 529 |
|
|
2023
Q3 | $1.07M | Sell |
19,840
-15
| -0.1% | -$838 | 0.01% | 527 |
|
|
2023
Q2 | $1.11M | Buy |
19,855
+2,250
| +13% | +$125K | 0.01% | 529 |
|
|
2023
Q1 | $961K | Buy |
17,605
+40
| +0.2% | +$2.19K | 0.01% | 547 |
|
|
2022
Q4 | $997K | Sell |
17,565
-170
| -1% | -$9.38K | 0.01% | 509 |
|
|
2022
Q3 | $897K | Buy |
17,735
+2,420
| +16% | +$131K | 0.01% | 518 |
|
|
2022
Q2 | $824K | Buy |
15,315
+70
| +0.5% | +$3.84K | 0.01% | 550 |
|
|
2022
Q1 | $881K | Buy |
15,245
+470
| +3% | +$26.2K | 0.01% | 584 |
|
|
2021
Q4 | $888K | Buy |
14,775
+205
| +1% | +$11.7K | 0.01% | 594 |
|
|
2021
Q3 | $804K | Buy |
14,570
+910
| +7% | +$52K | 0.01% | 594 |
|
|
2021
Q2 | $745K | Sell |
13,660
-1,705
| -11% | -$90.2K | 0.01% | 540 |
|
|
2021
Q1 | $776K | Sell |
15,365
-1,450
| -9% | -$72.9K | 0.01% | 436 |
|
|
2020
Q4 | $827K | Sell |
16,815
-2,355
| -12% | -$111K | 0.01% | 407 |
|
|
2020
Q3 | $871K | Sell |
19,170
-1,605
| -8% | -$72.7K | 0.01% | 360 |
|
|
2020
Q2 | $896K | Sell |
20,775
-120
| -0.6% | -$5.07K | 0.01% | 346 |
|
|
2020
Q1 | $785K | Buy |
20,895
+585
| +3% | +$24.1K | 0.01% | 333 |
|
|
2019
Q4 | $876K | Buy |
20,310
+5,015
| +33% | +$203K | 0.01% | 363 |
|
|
2019
Q3 | $597K | Sell |
15,295
-630
| -4% | -$24.2K | 0.01% | 413 |
|
|
2019
Q2 | $622K | Sell |
15,925
-860
| -5% | -$32.6K | 0.01% | 409 |
|
|
2019
Q1 | $651K | Sell |
16,785
-345
| -2% | -$13.1K | 0.01% | 371 |
|
|
2018
Q4 | $619K | Buy |
17,130
+4,000
| +30% | +$153K | 0.01% | 366 |
|
|
2018
Q3 | $533K | Buy |
13,130
+800
| +6% | +$30.9K | 0.01% | 429 |
|
|
2018
Q2 | $439K | Sell |
12,330
-3,470
| -22% | -$122K | 0.01% | 474 |
|
|
2018
Q1 | $545K | Buy |
15,800
+2,255
| +17% | +$81.1K | 0.01% | 425 |
|
|
2017
Q4 | $472K | Sell |
13,545
-335
| -2% | -$11.6K | 0.01% | 463 |
|
|
2017
Q3 | $477K | Buy |
13,880
+1,560
| +13% | +$52.6K | 0.01% | 449 |
|
|
2017
Q2 | $410K | Buy |
12,320
+2,185
| +22% | +$69.8K | 0.01% | 469 |
|
|
2017
Q1 | $292K | Hold |
10,135
| – | – | ﹤0.01% | 498 |
|
|
2016
Q4 | $292K | Buy |
+10,135
| New | +$294K | ﹤0.01% | 498 |
|
Other funds holding IYH
PAS
AFG
NO
FCFC
LWANC
IFG
FTS
YIH
KCM
Davenport & Co's IYH Position: Q2 2026 in Review
Davenport & Co reduced its iShares US Healthcare ETF (IYH) stake by 0.81% in Q2 2026, selling an estimated $13.5K and leaving 26,354 shares worth $1.77M. The position accounts for 0.01% of the portfolio, ranked #600.
Davenport & Co first reported a position in IYH in Q4 2016 and has held it in 39 quarters since. 91 funds tracked by Wall St. Rank hold IYH as of Q2 2026.
- Davenport & Co held 26,354 shares of iShares US Healthcare ETF worth $1.77M as of Q2 2026.
- Davenport & Co sold 215 iShares US Healthcare ETF shares in Q2 2026, an estimated $13.5K.
- iShares US Healthcare ETF made up 0.01% of Davenport & Co's portfolio in Q2 2026, its #600 holding.
- Davenport & Co first reported a position in iShares US Healthcare ETF in Q4 2016 and has held it in 39 quarters since.
- 91 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q2 2026.
Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.